Charles R. Thomas

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

Mack Roach, Michelle DeSilvio, C.A. Lawton et al. · Journal of Clinical Oncology · 2003 · 639 citations

Medicine, Oncology, Radiation Oncology +17

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin

Leonard L. Gunderson, Kathryn Winter, Jaffer A. Ajani et al. · Journal of Clinical Oncology · 2012 · 587 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors

Joost J. Nuyttens, Philip F. Rust, Charles R. Thomas et al. · Cancer · 2000 · 484 citations · Full text

Medicine, Oncology, Surgery +14

An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions

C.A. Lawton, Michelle DeSilvio, Mack Roach et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 480 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

Julio García‐Aguilar, Lindsay A. Renfro, Oliver S. Chow et al. · The Lancet Oncology · 2015 · 424 citations · Full text

Medicine, Oncology, Surgery +17